XML 23 R9.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:      
Net income $ 164,375 $ 108,839 $ 105,268
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 19,186 14,867 12,311
Amortization of premium on available-for-sale securities 2,979 729 1,353
(Gain) loss on deferred compensation plan investments (4,592) (3,806) 255
Deferred taxes, net (1,627) (577) (843)
Stock-based compensation expense 85,551 78,699 60,607
Other (1,072) (259) 22
Changes in operating assets and liabilities:      
Accounts receivable (14,123) 2,512 (18,079)
Inventories (29,503) 8,865 (37,060)
Other assets (3,003) (10,204) (1,075)
Accounts payable 10,410 3,048 871
Accrued compensation and related benefits 18,524 7,496 3,806
Income tax liabilities 747 (1,355) 6,923
Other accrued liabilities 19,951 7,449 7,092
Net cash provided by operating activities 267,803 216,303 141,451
Cash flows from investing activities:      
Purchases of property and equipment (55,639) (95,806) (22,526)
Proceeds from sales of property and equipment 29 9,268 0
Acquisition of in-place leases 0 (981) 0
Purchases of short-term investments (334,947) (212,562) (99,199)
Proceeds from maturities and sales of short-term investments 357,092 135,801 109,131
Purchases of long-term investments (3,316) 0 0
Proceeds from sales of long-term investments 300 250 2,000
Contributions to deferred compensation plan, net (2,696) (3,082) (4,146)
Net cash used in investing activities (39,177) (167,112) (14,740)
Cash flows from financing activities:      
Property and equipment purchased on extended payment terms (5,357) (683) (749)
Proceeds from common stock issued under the employee equity incentive plan 18,767 16,650 10,637
Proceeds from common stock issued under the employee stock purchase plan 3,819 3,277 3,028
Dividends and dividend equivalents paid (88,786) (67,294) (47,475)
Net cash used in financing activities (71,557) (48,050) (34,559)
Effect of change in exchange rates 4,926 (883) (2,208)
Net increase in cash, cash equivalents and restricted cash 161,995 258 89,944
Cash, cash equivalents and restricted cash, beginning of period 173,076 172,818 82,874
Cash, cash equivalents and restricted cash, end of period 335,071 173,076 172,818
Supplemental disclosures for cash flow information:      
Cash paid for taxes 1,405 10,700 7,134
Non-cash investing and financing activities:      
Liability accrued for property and equipment purchases 7,839 7,803 1,737
Liability accrued for dividends and dividend equivalents $ 27,507 $ 21,955 $ 16,319